TOPICORT (desoximetasone)
Topicort (desoximetasone ointment USP) 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Details
- Status
- Prescription
- First Approved
- 1977-02-28
- Patent Cliff
- 2028
- Routes
- TOPICAL
- Dosage Forms
- OINTMENT, CREAM, GEL, SPRAY
TOPICORT Approval History
What TOPICORT Treats
10 FDA approvalsOriginally approved for its first indication in 1977 . Covers 10 distinct patient populations.
- Other (10)
Other
(10 approvals)- • Approved indication (Feb 1977)
- • Approved indication (Mar 1982)
- • Approved indication (Oct 1983)
- • Approved indication (Jan 1985)
- • Approved indication (Nov 1990)
- • Approved indication (Nov 1990)
- • Approved indication (Jun 1996)
- • Approved indication (Jul 1998)Letter
- • Approved indication (Apr 2013)Label Letter
- • Approved indication (Oct 2021)Label Letter
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TOPICORT FDA Label Details
Indications & Usage
FDA Label (PDF)Topicort ® (desoximetasone ointment USP) 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Pro Intelligence Preview
Deep insights for TOPICORT
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2028
- • 2 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.